Growing numbers of publications, studying patients and/or using cell or animal disease models, link profilins to various diseases: in cancers, PFN1 as well as PFN2 are reported to either act as tumor suppressors or possess oncogenic potential, depending on the studied cancer cell type (for review Pimm et al., 2020). Here, PFN2 is linked to cancer.